Drug Profile
Baclofen extended release - Sun Pharma Advanced Research Company
Alternative Names: Baclofen ER capsules - Sun Pharma Advanced Research Company; Baclofen GRS; SPARC1104Latest Information Update: 09 Mar 2022
Price :
$50
*
At a glance
- Originator Sun Pharma Advanced Research Company
- Class Aminobutyric acids; Antispastics; Muscle relaxants; Small molecules
- Mechanism of Action GABA B receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Muscle spasticity
- Suspended Alcoholism
Most Recent Events
- 09 Mar 2022 No development reported - Phase-III for Muscle spasticity in Ukraine, Germany, Hungary, Russia (PO)
- 24 Jun 2019 Sun Pharma Advanced Research Company completes a phase III trial in Muscle spasticity in the US, Germany, Hungary, Russia and Ukraine (PO) (NCT01457352) (EudraCT2016-001356-22)
- 28 Apr 2017 Sun Pharma Advanced Research Company completes a phase II trial for Muscle spasticity in USA, Russia and Ukraine (NCT02027025)